Omzo vs SnagRx: Pricing, compounded meds, clinician networks
Omzo vs SnagRx: both are direct-pay telehealth options for GLP-1 treatment, but they differ on pricing model, pharmacy relationships, and whether branded prescriptions are supported. Quick verdict: SnagRx is best for predictable low all-in pricing on a 12-month plan with named 503A pharmacies; Omzo is better if you want clinician-guided programs that may include prescriptions for branded medications and a compounded option starting at $179.
Explore Omzo clinician-guided plans
Key differences at a glance: Omzo vs SnagRx
This comparison focuses on the most distinctive differences supported by source material: pricing structure and plans, compounded versus branded medication handling, named pharmacies and shipping speed, clinician network and scope, and guarantees or refund policies.
1. Pricing structure and commitments
SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month as 12-month plan rates; month-to-month equivalents are $99 and $149. SnagRx states the rate is locked flat at every dose for the life of treatment on the annual plan. Omzo lists compounded semaglutide starting at $179 and tirzepatide starting at $279 as single starting prices. The sources show SnagRx aims for bottom-of-market annual pricing, while Omzo presents per-treatment starting prices and clinician-guided program fees.
See SnagRx price plans and terms
2. Compounded medication versus branded prescriptions
Both providers offer compounded GLP-1 medications and include regulatory qualifiers. Omzo describes a Compounded Medication Program where compounded drugs are prepared and shipped by a state-licensed sterile compounding pharmacy and explicitly states these compounded drugs are not FDA-approved. Omzo also notes providers may alternatively write prescriptions for FDA-approved branded medications such as Ozempic or Wegovy but that Omzo does not sell or ship branded products. SnagRx offers compounded semaglutide and tirzepatide only and states its compounds are produced in FDA-regulated facilities but are not FDA-approved finished products.
3. Named pharmacies, shipping and turnaround
SnagRx names its US 503A partner pharmacies and advertises next-day UPS or FedEx shipping in temperature-controlled packaging, with clinician review typically within five hours and next-day shipping for approved orders. Omzo states fast, discreet delivery and that compounded medications are produced in FDA-registered facilities, but captured evidence does not list specific partner pharmacies or specific review times in the source row.
Check Omzo shipping and medication options
4. Clinician networks and how care is delivered
Omzo connects users with licensed U.S. providers who review plans and determine medication eligibility; Omzo emphasizes clinician-guided plans reviewed by licensed U.S. providers and states clinicians make the final determination to prescribe. SnagRx operates with a clinician network through OpenLoop Health that reviews intake answers, screens for exclusions, and meets with individuals after checkout; SnagRx states clinicians typically review within five hours and that OpenLoop clinicians determine prescription eligibility. Both stress clinician review and judgment; SnagRx names its clinician network while Omzo describes third party networks of U.S.-licensed clinicians.
5. Guarantees, refunds, and program extras
SnagRx advertises a full refund if a prescription is declined and a 6-month weight-loss guarantee with terms that apply. SnagRx also states no membership fee, cancel anytime, and that pricing is locked at renewal on the annual plan. Omzo explicitly states no guarantees on weight loss and that individual results may vary, and emphasizes that it is not a medical practice and that eligibility and results are not guaranteed. The captured Omzo evidence does not show a refund or outcome guarantee.
Comparison table: Omzo vs SnagRx
| Criteria | Omzo | SnagRx |
|---|---|---|
| Starting price (semaglutide) | $179 starting | $69/month on 12-month plan ($99 month-to-month) |
| Medication type offered | Compounded semaglutide and tirzepatide; providers may write prescriptions for branded meds | Compounded semaglutide and tirzepatide only |
| Pharmacies named | Compounded meds shipped by state-licensed sterile compounding pharmacy; no named partners in captured evidence | Names four US 503A partner pharmacies |
| Clinician network | Licensed U.S. providers review plans; clinicians determine eligibility | OpenLoop Health clinician network; typical review within five hours |
| Pricing model | Per-treatment starting prices and clinician-guided program fees | Flat locked price at every dose on annual plan; month-to-month higher |
| Refunds and guarantees | No guarantees; results vary; eligibility not guaranteed | Full refund if prescription declined; 6-month weight-loss guarantee terms apply |
How to choose between Omzo and SnagRx
If your priority is the lowest locked all-in price over a full titration and named pharmacy partners with fast shipping, SnagRx is supported by the source as best for cost-driven patients on a 12-month plan. If you value clinician-guided programs that may include the option to receive a prescription for an FDA-approved branded medication and do not mind higher starting prices for compounded programs, Omzo is supported as the better fit.
Go to SnagRx to review annual plan details
Compare Omzo clinician options now
Final recommendation
In short, Omzo vs SnagRx differs mainly by pricing model, handling of branded prescriptions, named pharmacy transparency, clinician network naming, and guarantees. Choose SnagRx if predictable low annual pricing, named 503A pharmacies, and fast next-day shipping matter most. Choose Omzo if you want clinician-guided programs that may include branded prescription options and are comfortable confirming eligibility, costs, renewal terms and state availability before enrollment.
Primary keyword: Omzo vs SnagRx